Blog | ryans-quest

$1 Million in Funding Available to Drive Therapies for Duchenne Muscular Dystrophy

HAMILTON, N.J. and STATEN ISLAND, N.Y., Aug. 21, 2018 /PRNewswire-iReach/ -- Several gene therapies for Duchenne muscular dystrophy have...

Families of Boys with Duchenne Muscular Dystrophy Band Together to Fund Research

BALTIMORE, MD – (April 12, 2017) Three grassroots foundations founded by the families of young boys diagnosed with Duchenne muscular...

DMD Therapeutics Inc. Receives Funding from DMD Foundations to Develop DMD-813 for Treatment of Duch

SEATTLE, Feb. 24 2017 /PRNewswire/ -- DMD Therapeutics, Inc., a start-up biotech company, is developing proprietary therapeutics for...

Two Nonprofit Organizations Award Iowa State University $150,000 for Muscular Dystrophy Research

AMES, Iowa — Ryan’s Quest and Michael’s Cause, two nonprofit organizations, have provided a $150,000 grant to Iowa State University to...

Michael's Cause, Ryan's Quest, Save Our Sons, Pietro's Fight, and Foundation LaForce Pro

HAMILTON, N.J., March 24, 2016 /PRNewswire-iReach/ -- Ryan's Quest, a New Jersey based non-profit organization dedicated to finding...

The Jett Foundation, Michael’s Cause and Ryan’s Quest Donate $15,000 to Scientific Committee Reviewi

Dec.4, 2015 — Three Duchenne muscular dystrophy nonprofits have donated $5,000 each to TREAT-NMD Advisory Committee for Therapeutics...

Ryan’s Quest Clinical Trial Grant for Steroid Alternative

Hamilton, New Jersey, August 3, 2015—The Ryan’s Quest Foundation, a non-profit organization specific to Duchenne muscular dystrophy,...

NEWS: Akashi Therapeutics Reports Positive Clinical Data on HT-100 in Patients with Duchenne Muscula

Interim Clinical Data from Ongoing Phase 1b/2a Clinical Program Highlights Statistically Significant Improvements in Muscle Strength...

NEWS: First Duchenne Muscular Dystrophy Patient Treated in Follistatin Gene Therapy Trial

Cleveland and Columbus, OH, April 9, 2015—Milo Biotechnology announced the first Duchenne muscular dystrophy (DMD) patient was treated...

No tags yet.